The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Integrated Biopharma's current ratio for the quarter that ended in Mar. 2024 was 2.63.
Integrated Biopharma has a current ratio of 2.63. It generally indicates good short-term financial strength.
The historical rank and industry rank for Integrated Biopharma's Current Ratio or its related term are showing as below:
INBP'
s Current Ratio Range Over the Past 10 Years
Min: 0.76 Med: 1.13 Max: 3.39
Current: 2.63
During the past 13 years, Integrated Biopharma's highest Current Ratio was 3.39. The lowest was 0.76. And the median was 1.13.
INBP's Current Ratio is ranked better than 71.97% of 1916
companies
in the Consumer Packaged Goods industry
Industry Median: 1.66
vs INBP: 2.63
Integrated Biopharma Current Ratio Historical Data
The historical data trend for Integrated Biopharma's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Integrated Biopharma's Current Ratio
For the Packaged Foods subindustry, Integrated Biopharma's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integrated Biopharma's Current Ratio Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Integrated Biopharma's Current Ratio distribution charts can be found below:
* The bar in red indicates where Integrated Biopharma's Current Ratio falls into.
Integrated Biopharma Current Ratio Calculation
The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.
Integrated Biopharma's Current Ratio for the fiscal year that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integrated Biopharma (OTCPK:INBP) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Integrated Biopharma Current Ratio Related Terms
Thank you for viewing the detailed overview of Integrated Biopharma's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Integrated Biopharma (Integrated Biopharma) Business Description
Integrated Biopharma Inc is a pharmaceutical company engaged in manufacturing, distributing, marketing, and selling vitamins, nutritional supplements, and herbal products. It operates in two segments; Contract Manufacturing and Other Nutraceutical Businesses. It serves the needs of the nutraceutical industry by directly doing business as Chem International Inc. and through its operating subsidiaries; Manhattan Drug Company, Inc., AgroLabs, Inc., IHT Health Products, Inc. and MDC Warehousing and Distribution, Inc. The company generates maximum revenue from the Contract Manufacturing segment. The business operates and generates the majority of revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
INBP has been successfully added to your 